NishaSaraJosephMD

Oncology • Atlanta, GA

Physician

Join to view full profile

Dr. Joseph is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Joseph's full profile

Already have an account?

Office
69 Jesse Hill Jr Dr Se
Atlanta, GA 30303
Phone+1 404-251-8787

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2015 - 2018
Ohio State University College of MedicineClass of 2012

Certifications & Licensure

GA State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma Start of enrollment: 2021 Aug 01
Recruiting
Phase 2

Publications & Presentations

PubMed

134 citations
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
Nisha Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar, Craig C. Hofmeister, Dhwani Almaula
Journal of Clinical Oncology. 2020-04-16
3 citations
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, Craig C Hofmeister, Vikas Gupta
Blood Cancer Journal. 2023-02-20
93 citations
Daratumumab in multiple myeloma.
Ajay K. Nooka, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha Joseph, Thomas L. Heffner
Cancer. 2019-07-15

Abstracts/Posters

Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
Nisha Joseph, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Assessing Patient Fitness for Transplant in Multiple MyelomaNovember 18th, 2024
Hospital Team Protected Patients by Prepping for Covid-19 in JanuaryJune 26th, 2020

Professional Memberships

Society of Hospital Medicine - SHM
Member